DIOSVax is a biotech startup working to revolutionise the way humanity protects itself from infectious disease and emerging pathogens.
The company is named after its core technology, DIOSynVax (Digitally designed, Immune Optimised Selected and Synthesized Vaccines), a new system that will significantly accelerate vaccine development and achieve dramatic improvements to the protection against emerging and re-emerging pathogens.
Company Details
- Employees
- 23
- Founded
- -
- Address
- Cambridge, Cambridgeshire Cb3 0es, Gb
- en****@****vax.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- diosvax.com
- HQ
- Cambridge, Cambridgeshire
Diosynvax Questions
Diosynvax's website is diosvax.com
Diosynvax's LinkedIn profile is https://uk.linkedin.com/company/diosvax
Diosynvax has
23 employees.
View email and phone details for 23
employees at Diosynvax.
Diosynvax's industry is
Biotechnology Research
Diosynvax's top competitors are
Abselion,
Mesenbio,
Prokarium,
Baseimmune,
Vismederi Group,
Magnitude Biosciences Ltd,
Red Queen Therapeutics,
Achilles Therapeutics Plc,
Barinthus Biotherapeutics,
Cosyne Therapeutics.
Diosynvax's support email address is enquiries@diosvax.com
Diosynvax's categories are Biotechnology Research
Diosynvax's founding year is 2017
